Two structurally modified compounds derived from an anti-inflammatory metabolite demonstrated enhanced anti-inflammatory ...
The recommendations surround important updates to standard criteria that are commonly used despite being decades old.
Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, which are adaptive immune cells, in triggering and sustaining colitis occurring ...
Can Surgery Cure Ulcerative Colitis? Alan Moss, MD, chief scientific officer of the Crohns & Colitis Foundation, clearly explains the surgeries available to people with ulcerative colitis, and their ...
Ulcerative colitis (UC) is a chronic inflammatory disease of the gastrointestinal tract, which is closely related to gut barrier dysfunction. Emerging evidence shows that interleukin-22 (IL-22) ...
Oral presentation to highlight early endoscopic improvement and evidence of PDE4 target engagement in fibrostenotic Crohn’s diseaseThree ...
Emerging therapies for ulcerative colitis treatment, such as Obefazimod (Abivax), Tulisokibart (Merck), Olamkicept (Ferring Pharmaceuticals), Afimkibart (Roche), Icotrokinra (Johnson & ...
Four Canadian research teams will investigate new approaches to understanding, treating and preventing Crohn’s disease and ulcerative colitisTORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- As Canada’s ...
Add Yahoo as a preferred source to see more of our stories on Google. "Debilitating digestive issues dominated my life because I couldn't go longer than a half hour without going to the bathroom," ...
Abivax (NASDAQ:ABVX) shares fell sharply on Tuesday after investors focused on reports of rare malignancy cases in a late-stage clinical trial, overshadowing better-than-expected efficacy results for ...
In a preclinical chronic colitis model, Tvardi’s oral small molecule accumulated in the colon at approximately 8-fold higher concentrations than ...
Can Surgery Cure Ulcerative Colitis? Alan Moss, MD, chief scientific officer of the Crohns & Colitis Foundation and director of the Crohn's and colitis program at Boston Medical Center, clearly ...